The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...

Are you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

We tend to think of COVID-19 as a respiratory illness. But, like many viruses, COVID can also affect your skin and cause ...

Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety ...

No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...

Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...